Valuation Celltrion, Inc.

Stocks

End-of-day quote Korea S.E. Other stock markets 10/07/2026			5-day change	1st Jan Change
1,75,200.00 ^KRW	+1.21%		-4.58%	+1.64%

07/07	Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA	MT
03/07	South Korean Shares Jump on Bargain-Hunting, Chip Stock Gains	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,75,92,583	2,30,00,359	2,79,70,378	4,03,65,453	3,96,02,284	4,01,78,131	-	-
Change	-	-16.64%	21.61%	44.32%	-1.89%	1.45%	-	-
Enterprise Value (EV) ¹	27,117	23,236	29,280	41,531	42,173	42,220	41,606	40,868
Change	-	-14.31%	26.01%	41.84%	1.55%	0.11%	-1.45%	-1.77%
P/E	47.2x	41.6x	53.7x	91.7x	38.8x	27.1x	24x	20.9x
PBR	6.87x	5.34x	2.46x	2.2x	2.32x	2.21x	2.03x	1.87x
PEG	-	-9.54x	-20.3x	-2.1x	0x	0.6x	1.9x	1.4x
Capitalization / Revenue	14.6x	10.1x	12.9x	11.3x	9.51x	7.55x	6.5x	5.83x
EV / Revenue	14.3x	10.2x	13.5x	11.7x	10.1x	7.93x	6.73x	5.93x
EV / EBITDA	27.9x	26.6x	32.6x	45.6x	29x	19.9x	16.9x	14.7x
EV / EBIT	36x	35.9x	44.9x	84.4x	36.1x	23.4x	19.4x	16.6x
EV / FCF	46x	-211x	89.5x	54.2x	78.4x	33.8x	31.9x	28x
FCF Yield	2.17%	-0.47%	1.12%	1.85%	1.28%	2.96%	3.14%	3.57%
Dividend per Share ³	628.9	-	436.1	686.8	714.3	736	799.7	860.4
Rate of return	0.38%	-	0.25%	0.4%	0.41%	0.42%	0.46%	0.49%
EPS ³	3,515	3,362	3,273	1,873	4,438	6,476	7,308	8,402
Distribution rate	17.9%	-	13.3%	36.7%	16.1%	11.4%	10.9%	10.2%
Net sales ¹	1,891	2,284	2,176	3,557	4,162	5,321	6,181	6,890
EBITDA ¹	972.1	873.6	897.2	910.3	1,456	2,120	2,468	2,787
EBIT ¹	753.9	647.2	651.5	492	1,168	1,807	2,148	2,467
Net income ¹	575.1	533.2	535.6	422.7	1,030	1,484	1,698	1,951
Net Debt ¹	-475.5	235.5	1,310	1,165	2,571	2,041	1,427	689.5
Reference price ³	1,66,042.75	1,39,979.07	1,75,736.96	1,71,703.30	1,72,380.95	1,75,200.00	1,75,200.00	1,75,200.00
Nbr of stocks (in thousands)	1,66,178	1,64,313	1,59,160	2,35,088	2,29,737	2,29,327	-	-
Announcement Date	16/02/22	03/03/23	29/02/24	25/02/25	04/02/26	-	-	-

¹KRW in Million²KRW in Billions³KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CELLTRION, INC.	26.73x	7.84x	19.68x	0.43%	2.63TCr
LONZA GROUP AG	35.02x	6.15x	19.02x	0.94%	5.04TCr
REVOLUTION MEDICINES, INC.	-23.93x	350.56x	-22.64x	-.--%	4.06TCr
IQVIA HOLDINGS INC.	25.43x	2.81x	12.14x	-.--%	3.49TCr
BEONE MEDICINES AG	46.36x	4.58x	29.24x	-.--%	3.37TCr
MEDPACE HOLDINGS, INC.	31.59x	5.09x	23.2x	-.--%	1.53TCr
EUROFINS SCIENTIFIC SE	23.89x	2.03x	8.94x	1.12%	1.37TCr
ICON PUBLIC LIMITED COMPANY	23.89x	1.9x	11.51x	-.--%	1.29TCr
ABIVAX	-33.54x	128.5x	-36.58x	-.--%	1.21TCr
Average	17.27x	56.61x	7.17x	0.28%	2.67TCr
Weighted average by Cap.	19.42x	69.58x	8.95x	0.31%